Showing results (131-140 of 280) with videos related to

Sort By:
Pageof 28
JAMA Network Open|December 9, 2024
Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate CancerNeeraj Agarwal, Daniel J George, Zachary Klaassen, et al.
NPJ Precision Oncology|February 24, 2023
Rewiring of the N-Glycome with prostate cancer progression and therapy resistanceWilliam Butler, Colin McDowell, Qing Yang, et al.
Cancer Investigation|April 4, 2017
Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell CancerNrupen A Bhavsar, Michael R Harrison, Bradford R Hirsch, et al.
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
Urology|February 20, 2004
Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancerDaniel J George, Meredith M Regan, William K Oh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Patricia Creel, James Turnbull, et al.
Urology|August 16, 2005
Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 studyMary-Ellen Taplin, Daniel J George, Susan Halabi, et al.
Frontiers in Oncology|February 7, 2019
Sources of Frustration Among Patients Diagnosed With Renal Cell CarcinomaCristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancerPhillip G Febbo, Jerome P Richie, Daniel J George, et al.
Clinical Genitourinary Cancer|April 16, 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate CancerDaniel J George, Fred Saad, Michael S Cookson, et al.
Pageof 28